Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Genflow Biosci (GENF) Share Price

Price 0.725p on 27-06-2025 at 18:00:06
Change 0.00p 0%
Buy 0.75p
Sell 0.70p
Buy / Sell GENF Shares
Last Trade: Sell 2,455.00 at 0.7199p
Day's Volume: 179,801
Last Close: 0.725p
Open: 0.725p
ISIN: GB00BP2C3V08
Day's Range 0.725p - 0.725p
52wk Range: 0.725p - 2.60p
Market Capitalisation: £3m
VWAP: 0.711736p
Shares in Issue: 454m

Genflow Biosci (GENF) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 2,455 0.7199p Ordinary
15:50:58 - 27-Jun-25
Sell* 673 0.7199p Ordinary
15:47:48 - 27-Jun-25
Sell* 2,493 0.717p Ordinary
15:39:14 - 27-Jun-25
Sell* 100,000 0.717p Ordinary
15:38:33 - 27-Jun-25
Sell* 140 0.7199p Ordinary
15:07:47 - 27-Jun-25
Sell* 3,456 0.7199p Ordinary
12:58:39 - 27-Jun-25
Sell* 57,635 0.7001p Ordinary
12:57:59 - 27-Jun-25
Sell* 55 0.7001p Ordinary
10:21:52 - 27-Jun-25
Sell* 6,447 0.7177p Ordinary
09:44:50 - 27-Jun-25
Sell* 6,447 0.7177p Ordinary
09:25:47 - 27-Jun-25
See more Genflow Biosci trades

Genflow Biosci (GENF) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Jun 2025 (Fri) 0.725 0.725 0.725 0.725 179,801
26th Jun 2025 (Thu) 0.725 0.725 0.725 0.725 558,327
25th Jun 2025 (Wed) 0.775 0.775 0.725 0.725 2,779,195
24th Jun 2025 (Tue) 0.775 0.775 0.775 0.775 2,014,629
23rd Jun 2025 (Mon) 0.775 0.775 0.775 0.775 599,466
20th Jun 2025 (Fri) 0.775 0.816 0.775 0.775 233,606
19th Jun 2025 (Thu) 0.775 0.80 0.775 0.775 141,530
18th Jun 2025 (Wed) 0.775 0.775 0.775 0.775 25,998
17th Jun 2025 (Tue) 0.775 0.775 0.775 0.775 779,555
16th Jun 2025 (Mon) 0.775 0.775 0.775 0.775 712,189
13th Jun 2025 (Fri) 0.775 0.775 0.775 0.775 846,872
12th Jun 2025 (Thu) 0.775 0.775 0.775 0.775 256,976
11th Jun 2025 (Wed) 0.80 0.80 0.775 0.775 5,504,566
10th Jun 2025 (Tue) 0.80 0.80 0.80 0.80 3,566,900
9th Jun 2025 (Mon) 0.85 0.85 0.775 0.80 3,558,256
6th Jun 2025 (Fri) 0.85 0.85 0.85 0.85 1,762,758
5th Jun 2025 (Thu) 0.85 0.85 0.85 0.85 43,726
4th Jun 2025 (Wed) 0.85 0.85 0.85 0.85 1,123,077
3rd Jun 2025 (Tue) 0.85 0.85 0.85 0.85 389,600
2nd Jun 2025 (Mon) 0.85 0.85 0.85 0.85 3,033,416
30th May 2025 (Fri) 0.875 0.875 0.85 0.85 2,176,700
29th May 2025 (Thu) 0.90 0.90 0.875 0.875 168,613
See more Genflow Biosci price history

Genflow Biosci (GENF) Regulatory News

Date Source Headline
17th Jun 2025 7:00 am RNS-R Corporate Update
12th Jun 2025 10:16 am RNS Result of AGM
30th May 2025 3:20 pm RNS Total Voting Rights
28th May 2025 7:00 am RNS-R Genflow Signs Master Services Agreement
22nd May 2025 10:51 am RNS AGM Notice
15th May 2025 7:00 am RNS-R Key SIRT6 Patent Application
12th May 2025 10:50 am RNS Holding(s) in Company
9th May 2025 7:00 am RNS Share Subscription, Director's Dealing and Update
30th Apr 2025 3:29 pm RNS Final Results
14th Apr 2025 7:00 am RNS-R Launch of AI-Powered Partnership
See more Genflow Biosci regulatory news

Genflow Biosci (GENF) Share News

EARNINGS AND TRADING: Ondine widens loss as research expenses rise

15th May 2025 14:30

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Genflow Biosciences says investment a vote of confidence

9th May 2025 18:42

Genflow Biosciences PLC - London-based biotechnology firm, which has research facilities in Belgium - raises GBP500,000 via an allotment to Chief Executive Eric Leire of 62.5 million shares at 0.8 pence each. The net proceeds will be used to advance a proof-of-concept trial evaluating the safety and efficacy of its therapeutic candidate in aged dogs, potentially being also a key translational model for age-related conditions in humans. On allotment, Leire agrees to sell these shares at the same price to an already identified purchaser. Leire says: "This investment, without applying any discount, is a strong vote of confidence in our science." He adds: "With this support, we are well-positioned to accelerate our research and bring us closer to delivering impactful solutions to patients." Read More

IN BRIEF: Genflow launches new ophthalmology development programme

10th Apr 2025 14:24

Genflow Biosciences PLC - London-based biotechnology firm, which has research facilities in Belgium - Launches new ophthalmology development programme, focused on advancing a novel gene therapy via its proprietary gene technology. The therapy will use a specially designed non-viral vector engineered for precise delivery of Genflow's SIRT6 to the eye. It is designed to counter ocular problems including several pathologies of the cornea and glaucoma. Read More

Genflow Biosciences enters 2025 with confidence in research progress

6th Jan 2025 14:28

(Alliance News) - Genflow Biosciences PLC on Monday saw shares climb after reporting "significant strides" in its 2024 research programmes. Read More

Genflow Biosciences secures EUR4 million for liver disease treatment

22nd Oct 2024 11:49

(Alliance News) - Genflow Biosciences PLC on Tuesday said it has secured EUR4 million in funding from the Wallonia region in Belgium, to support its gene therapy development work. Read More

See more Genflow Biosci news
FTSE 100 Latest
Value8,798.91
Change63.31

Login to your account

Forgot Password?

Not Registered